United Kingdom news from FierceBiotech
News
Ardana calls in administrators to find a buyer
Anyone looking for fresh signs of the faltering state of the UK's biotech industry need look no further than Ardana. Unable to engineer a speedy refinancing, sale or merger, the Scottish developer - Read more...
Big Pharma pulls out of U.K. trials
There's more bad news today for the U.K.'s drug development industry. Pfizer, Roche and Merck Serono have all decided to cut back on clinical research there, according to the Financial Times. The Read more...
Pharma turns cold shoulder to UK
Roche and Merck Serono recently sized up their chances to pass muster with the UK's cost-effectiveness regulators and decided to give NICE a pass. Analysts say that the clinical- and Read more...
UK out to make itself more attractive to drug developers
UK officials are shaking up their biomedical research industry in order to make the country a more attractive place for drug developers. A string of academic health science centers will combine Read more...
British biotech execs sour on industry’s 'dire' shape
Investors have sourced on publicly traded biotech companies in a big way. IPOs appear to be a less and less appealing way to cash out venture players. And don't look for any kind of a change Read more...
European investors sour on biotech market
There's a loud drumbeat of warnings coming from Europe over the sour state of biotech investing. Zhining Xu, an analyst at Seymour Pierce, tells the Financial Times that 2007 was a "Read more...
Finding no magic for 'Merlin,' Sir Evans shifts focus
Sir Christopher Evans' is scrapping Merlin Biosciences and transferring the early-stage venture funds to the newly-formed Excalibur, which will shift focus to late-stage therapies. That's bitter Read more...
Biopharma execs sign on to tout UK's R&D work
A high-profile crew of biopharma execs are signing on to help promote the life sciences industry in the UK. Chris Brinsmead, president of AstraZeneca U.K., will chair a 12-man strategy group for UK Read more...
Get more United Kingdom coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends